Vitalhub (TSE:VHI – Get Free Report) had its target price cut by analysts at TD from C$13.00 to C$9.50 in a research note issued on Monday, BayStreet reports. The firm currently has a “buy” rating on the stock. TD‘s price target would suggest a potential upside of 45.71% from the stock’s previous close.
Several other equities analysts have also weighed in on the stock. ATB Cormark Capital Markets reduced their price objective on shares of Vitalhub from C$12.00 to C$10.25 and set an “outperform” rating for the company in a research report on Monday. Canaccord Genuity Group set a C$15.00 target price on shares of Vitalhub and gave the stock a “buy” rating in a report on Friday, August 28th. Nine investment analysts have rated the stock with a Buy rating. According to data from MarketBeat, the stock has an average rating of “Buy” and an average price target of C$10.86.
View Our Latest Analysis on VHI
Vitalhub Trading Down 6.9%
VHI stock traded down C$0.48 during trading hours on Monday, hitting C$6.52. 481,442 shares of the stock traded hands, compared to its average volume of 297,780. The stock has a 50-day simple moving average of C$7.56 and a 200 day simple moving average of C$7.58. The company has a market cap of C$412.97 million, a P/E ratio of 54.33, a P/E/G ratio of 1.18 and a beta of 1.37. Vitalhub has a one year low of C$6.46 and a one year high of C$9.77.
Vitalhub (TSE:VHI – Get Free Report) last issued its quarterly earnings results on Thursday, November 12th. The company reported C$0.04 EPS for the quarter. Vitalhub had a net margin of 8.63% and a return on equity of 4.03%. The firm had revenue of C$31.91 million for the quarter. Analysts forecast that Vitalhub will post 0.23 earnings per share for the current year.
About Vitalhub
VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.
Further Reading
- Five stocks we like better than Vitalhub
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.
